In spite of the progress made in various modes of renal replacement therapies (RRT), arterial hypotension is still a frequent and potentially severe complication which can appear early or late during the course of dialysis. Regardless of its underlying cause, hypotension can develop either as an acute episode or as a more prolonged and persistent disorder. However, in contrast to arterial hypertension, hypotension and its significance on dialysis patient outcomes has received relatively little study.
Hypotension develops during hemodialysis in 10 to 50% of patients (1) . It is due chiefly to the decrease in blood volume induced by excessive ultrafiltration, lack of compensatory vasoconstriction and to autonomic insufficiency (2) (3) (4) (5) .
Arterial hypotension is less likely to occur in patients on chronic peritoneal dialysis (CPD) because this treatment mimics the "steady state" control of body fluid provided by normal kidneys (6, 7) . Despite this, severe hypotension also has been observed in these patients (7, 8) .
This paper describes our current knowledge regarding the prevalence, severity and the course of arterial hypotension in chronic peritoneal dialysis patients, and their clinical outcome, based on experience from our units and that of others (7, 9, 10, 11) .
Definition -prevalence of hypotension
Any acute abrupt fall in systolic blood pressure below 100 mm Hg may be described as a hypotensive episode, while arterial hypotension represents a relatively persistent decrease in BP, which calls for appropriate diagnosis and management.
In dialysis patients, arterial hypotension has been defined as a systolic blood pressure (SAP) of <100 mmHg (6, 12) or a drop in SAP to less than 90 mmHg (13) , or when the patient has had a hypotensive episode (SAP <100 mmHg) on at least two occasions (14) . In order to exclude temporary hypotensive BP readings, investigators in two recent studies have defined arterial hypotension as a systolic blood pressure equal to or less than 100 mmHg in two consecutive clinic visits, separated by a one-month interval (10, 11) .
Because of the various definitions in use, the prevalence of arterial hypotension varies. Twenty years ago, Khanna et al (9) studied CAPD patients treated at Toronto Western Hospital and found a high prevalence of symptomatic hypotension, namely 25% among 132 CAPD patients. In the same period other investigators (6, 7) reported an even higher prevalence of 54% among CAPD patients; at some point, 70% of them (38% of all CAPD patients) had symptoms of orthostatic dizziness. In 1996 Shetty et al (10) reported that hypotension was present in only 12% of 525 CAPD patients. Similarly, in a more recent retrospective evaluation, Malliara et al (11) found 81 hypotensive patients among 633 PD patients (12.8%) treated between 1995-2001 at two institutions (Toronto Western Hospital, Toronto, Canada and Division of Nephrology, Democritus University of Thrace, Alexandroupolis, Greece). It seems that the last two decades have seen a remarkable decrease in the prevalence of arterial hypotension as a complication of peritoneal dialysis treatment, which may be attributable to improvements in technique and to a better understanding of the patients' dialysis requirements. dysfunction seen in dialysis patients is often related to leftventricular concentric hypertrophy; in such patients, the margin between clinical under-and overhydration is very narrow, thus they are especially prone to symptomatic hypotension (15) .
In addition to good heart function, an individual on dialysis needs a well-functioning autonomic nervous system, to compensate for any decrease in blood pressure. In patients on chronic dialysis, the sympathetic nervous system that normally increases its activity during hypotension, shows decreased activity (16) or a reduced end-organ sensitivity to catecholamines (17) . It has been suggested that patients on continuous ambulatory peritoneal dialysis have impaired autonomic nervous function (18) , although, in most PD patients, during CAPD, blood pressure regulation in the supine and upright positions is found to be appropriate (9) .
Among the treatment-related factors, the most frequent cause of hypotension in CPD patients continues to be hypovolemia due to such causes as increased water and sodium removal by ultrafiltration (due to inappropriate use of hypertonic exchanges and/or diuretics) and low sodium intake (10, 11) .
Early attention to the role of sodium and water depletion in the pathophysiology of hypotension during peritoneal dialysis indicated that an important determinant of sodium loss in PD patients was the degree of ultrafiltration (6, 19, 20) . Thus the use of hypertonic dialysis solutions increase sodium loss, while one can decrease both ultrafiltration rate and sodium removal by using hypotonic exchanges (0.5% dextrose).
Also hypotension is a potential side effect of most antihypertensive agents currently in use, such as alpha blockers, central alpha agonists, diuretics, beta blockers, calcium-channel blockers, angiotensin-converting enzyme (ACE) inhibitors and arterial vasodilators.
Profile of CAPD patient who develop hypotension

Predisposing factors
In patients on dialysis, the presence of several comorbid conditions confer a higher risk for the development of hypotension because these may impair blood pressure control mechanisms and/or the patient's response to hypotensive disorders. These comorbid conditions include diabetes mellitus, autonomic dysfunction (primary or secondary), advanced age, heart failure, and malnutrition and inadequate dialysis. Commonly these patients show evidence of autonomic or baroreceptor failure (excessive venous pooling, vasodilatation) and disturbed cardiac function with systolic and diastolic dysfunction. Older age has been recognized as a risk factor for hypotension during dialysis because of impaired cardiopulmonary and baroreceptor reflexes (5) . Such failure of baroreceptor reflex mechanisms also contributes to the acute orthostatic changes seen clinically.
Early studies (18) (19) (20) have shown the more frequent development of hypotension in the elderly, in diabetics and in patients with congestive heart failure, although in some hypotensive patients the cause remains obscure (10, 11) . Despite this agreement, two studies of CPD patients that had different patient compositions with regards to age and 490 percentage of diabetics showed a similar prevalence of hypotension (10, 11) . Similarly, a study with a large cohort of 633 CAPD patients, found severe orthostatic hypotension (i.e. autonomic neuropathy) only in six of the 23 diabetic patients in that patient population (11) ; this calls into question the importance of autonomic neuropathy in the development of hypotension in such patients.
Arterial hypotension in PD patients
We believe that the fluid status of the patient may have the most profound influence on blood pressure control. Moreover, in addition to their direct action, several vasoactive drugs may impair the vascular compensatory response to hypovolemia, thus predisposing to hypotension.
Underlying causes
The most important factors for the clinical course and appropriate management of hypotensive peritoneal dialysis patients are the patients' clinical status and the underlying pathophysiology of hypotension. For this reason these patients may be divided into four representative groups (10, 11): a) hypotension due to hypovolemia, if they show clinical signs of intravascular fluid depletion and their BP is increased after a weight gain of at least 2 kg; b) hypotension due to heart failure if they have clinical features of congestive heart failure (CHF) or an echographically estimated ejection fraction (EF) ≤ 40%; c) hypotension due to the use of antihypertensive medications, if withdrawing or reducing these medications corrects the hypotension and finally d) patients who have hypotension of unknown etiology, in whom we could demonstrate none of these causes.
Using this classification Malliara et al (11) found that hypovolemia was the cause in approximately 40% of CAPD patients with hypotension, heart failure and antihypertensive medications being responsible in 18.5% and 13.6%, respectively; none of these three causes could be identified in 28% of hypotensive patients, who were consigned to the "unknown etiology" group.
Diabetes mellitus and numerous other comorbid conditions (ischemic heart disease, peripheral vascular disease, cerebrovascular disease, cancer, amyloidosis, chronic obstructive airway disease) were distributed uniformly among the patients in the four groups. We found no association between these entities and the development of hypotension. However patients in the "unknown" group showed a higher number of comorbid conditions and the diabetic patients in this group displayed a more severe orthostatic hypotension.
All groups of hypotensive CAPD patients showed no statistically significant differences with regards to laboratory findings or adequacy indices (Kt/V) (11) .
Comparing these more recent results with those of an earlier report from our institution (10) the most frequent cause of hypotension now is hypovolemia (40% vs. 25%), which may be attributed to the more frequent use of daily hypertonic exchanges. On the contrary, we estimated a proportional decrease for all other groups of patients; heart failure (18.5% vs. 23%), antihypertensive medications (13.6% vs. 18%), and patients with hypotension of "unknown" etiology (28% vs. 34%) (Fig. 1) .
Regarding the duration of CAPD before hypotension develops, Shetty et al (10) found that 56% of the hypotensive patients developed hypotension during the first six months after starting CAPD. In the recent evaluation (11) , that time was much longer (median 27 months).
Common clinical findings
Patients may complain of fainting, dizziness, nausea, light-headedness, occasional palpitations, blurred vision and even confusion; some CAPD patients may experience very subtle symptoms and, in them, the presence of hypotension may be recognizable only by measurement. Only 33% of the patients admitted to hospital for hypotension had symptomatic postural hypotension and dizziness (11) . (2001) and those of the retrospective study published by Shetty (1996) (10, 11) .
Interestingly 21% to 45% of the hypotensive patients, including those with hypovolemia (10, 11) had edema; probably other factors such as hypoproteinemia or use of calcium channel blockers may lead to edema, thus its presence does not exclude hypovolemia as the underlying cause of hypotension.
Obviously the more prominent clinical features are those related to cardiac diseases. Thus of those hypotensive patients who were evaluated by echocardiography, 46-53% had abnormal left ventricular function (EF < 40%) (10, 11) ; this is an important finding because in dialysis patients left ventricular dysfunction is associated with increased morbidity and mortality (21) (22) (23) (24) .
Mode of management and patient response
Most of these patients can be managed as outpatients. Only one-third is considered for hospitalization (11) , which may be indicated in the presence of severe orthostatic hypotension, evidence of fluid depletion or a cardiovascular disorder.
Important data in the evaluation of the underlying cause of hypotension is the patient's body weight (BW) as it is evaluated monthly at consecutive clinical visits and their target weight.
The initial treatment of arterial hypotension in CAPD patients is based upon its severity, the patient's clinical status and his/her symptoms, the available information about the latest PD scheme, which usually is prescribed monthly, and finally the provisional diagnosis concerning the underlying cause. One may consider that the blood pressure has been improved when therapeutic measures have achieved a constant increase in SAP ≥ 20 mmHg without any symptoms of orthostatic hypotension (10, 11) .
Commonly one modifies the PD prescription so as to decrease the tonicity of the daily hypertonic peritoneal exchanges and others reduce ultrafiltration rate and its contribution to the arterial hypotension. In addition one discontinues or decreases any antihypertensive medication. In more severe cases, IV fluid administration may have to be considered.
Also conversion to CCPD from CAPD has been successful in improving arterial hypotension in some patients when all other measures have failed (11) .
In patients with CHF, one should carefully increase the use of hypertonic exchanges in an attempt to improve cardiac function. Decreasing body weight, raised blood pressure in approximately 40% of CHF patients, while the remaining 60% remained hypotensive even with supplementary conservative measures (10, 11) . This option is important because CAPD is recognized to be a successful treatment for patients suffering severe congestive heart failure (25, 26) .
The "antihypertensive group" of hypotensive CPD patients, includes those who respond easily to withdrawal or reduction of their medication, when they suffer from no other concurrent disorder. Of course some antihypertensive medications (i.e. beta blockers and ACE inhibitors) may have to be continued in the presence of hypotension. Finally in the "unknown group", because no particular pathophysiology has been identified, one should try several combinations of the therapeutic measures described above, but improvement may be unpredictable.
Additional therapeutic measures may include the administration of antihypotensive drugs such as ephedrine, fludrocortisone and midrodrine, which are efficacious, well tolerated, safe and easy to administer (27) (28) (29) (30) . In a few patients who responded, midodrine in a dose of 7.5 mg/day in three divided doses of 2.5 mg gave a 20-25 mmHg increase in blood pressure (three patients responded and four did not) (10, 11) .
By these pathophysiologic-related measures, blood pressure may be controlled in 62 to 72 % of hypotensive CPD patients over a one to six month period (10, 11) . Hypotensive patients with hypovolemia and on antihypertensive medications are easier to manage than those with CHF and those in the "unknown" groups. The later two groups show an approximately 60% failure rate. For those patients who required hospitalization, Malliara et al (11) reported a mean hospital stay of 6.6 ± 2 days (range 4-34 days). The shortest mean treatment time was in the antihypertensive group (2.77 ± 1.6 months) and the longest was in the unknown group (5.0 ± 3.5 months).
Shetty et al (10) found also that hypotensive patients who have been on CPD for a longer time, had a higher success rate in BP stabilization.
Complications
After the clinical presentation of arterial hypotension, the most frequent complications were symptomatic coronary artery disease, cerebrovascular accidents and gangrene (10, 11) . In combination with the arterial hypotension, the main factors responsible for these complications were the presence of various comorbid conditions and the high prevalence of diabetes mellitus.
Outcome in hypotensive CAPD patients
The overall clinical outcome of patients who develop hypotension depends upon the severity of the hypotension, the patients' clinical condition and his/her response to therapy. Patients who responded easily with stabilization of their BP had a better clinical course; among them 26% to 60% remained on PD, whereas among patients who failed to improve only 13-28% remained on PD (Tab. II) (10, 11) .
Patients with congestive heart failure had the poorest prognosis; they showed a high death rate (66.7%) than the other groups over a mean period of 8.2 months after the development of hypotension (11) . On the contrary, hypovolemic patients had a better outcome, which may reflect their prompt response to fluid management.
However in a comparison of the overall survival rates after starting CPD, among the four groups, all hypotensive PD patients showed similar probabilities of overall survival (x 2 = 6.63, p= 0.08), regardless the etiology of hypotension (11) (Figs. 2, 3) . Thus three-year and five-year survival rates for all the patients were 78% and 54%, whereas for those in the hypovolemic, heart failure, antihypertensive and unknown groups they were 79% and 68%; 69% and 42%; 82% and 74%; and 77% and 44% respectively.
CONCLUSION
Arterial hypotension, although not as frequent as it is in HD patients, is still a serious complication among PD patients and occurs commonly early in the course of CAPD. Careful examination of the patients' signs and symptoms will classify the underlying etiology as hypovolemia, congestive heart failure or inappropriate use of antihypertensive medication. However in approximately one-quarter of hypotensive CAPD patients, the exact cause of hypotension remains obscure. Among all hypotensive patients, those with hypovolemia and those on antihypertensive medication show the best response, and the hypovolemic patients have the best outcome. On the contrary only 40% of the patients with heart failure and those with an unknown cause of hypotension respond to the therapeutic intervention. In the present state of our knowledge the precise estimation of the target weight, the cautious use and appropriate discontinuation of antihypertensive medication, and the judicious use of hypertonic exchanges are the best ways to prevent this hazardous complication. 
